<DOC>
	<DOCNO>NCT00514514</DOCNO>
	<brief_summary>The purpose study compare renal function immunosuppressive regimen different relevance calcineurin inhibitor ( CNI ) cyclosporine : standard dose CNI , low dose CNI , CNI free de novo kidney transplant patient 12 month therapy .</brief_summary>
	<brief_title>Study Investigating Standard Regimen de Novo Kidney Transplant Patients Versus Calcineurin Inhibitor ( CNI ) -Free Regimen CNI-low Dose Regimen</brief_title>
	<detailed_description />
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Basiliximab</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>Inclusion criterion Males female , age 18 70 year Recipients de novo cadaveric , live unrelated living relate kidney transplant Females capable become pregnant must negative serum pregnancy test within 7 day prior screen , required practice approve method birth control duration study period 6 week follow discontinuation study medication , even history infertility . Patients willing able participate study write informed consent obtain . Exclusion criteria More one previous renal transplantation Multiorgan recipient ( e.g. , kidney pancreas ) previous transplant organ , different kidney Patients receive kidney nonheart beat donor Donor age : &lt; 5 year &gt; 70 year Graft loss due immunological reason first year transplantation ( case secondary transplantation ) Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Everolimus</keyword>
	<keyword>mycophenolate</keyword>
	<keyword>CNI-free</keyword>
	<keyword>kidney transplantation</keyword>
</DOC>